These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regarding: Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Teebken OE; Bauermeister G; Pichlmaier AM Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):118. PubMed ID: 18440251 [No Abstract] [Full Text] [Related]
5. Stents (grafting) should be the primary treatment for symptomatic superficial femoral artery disease. Ansel GM Catheter Cardiovasc Interv; 2007 May; 69(6):886-9. PubMed ID: 17427903 [No Abstract] [Full Text] [Related]
6. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. Fischer M; Schwabe C; Schulte KL J Endovasc Ther; 2006 Jun; 13(3):281-90. PubMed ID: 16784314 [TBL] [Abstract][Full Text] [Related]
13. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. Saxon RR; Dake MD; Volgelzang RL; Katzen BT; Becker GJ J Vasc Interv Radiol; 2008 Jun; 19(6):823-32. PubMed ID: 18503895 [TBL] [Abstract][Full Text] [Related]
14. Modification of the Viabahn Padova sutureless technique for challenging anastomosis between a prosthetic graft and a circumferentially calcified target artery. Piazza M; Bonvini S; Ferretto L; Menegolo M; Frigatti P; Ricotta JJ; Grego F J Endovasc Ther; 2012 Jun; 19(3):457-60. PubMed ID: 22788901 [TBL] [Abstract][Full Text] [Related]
15. Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication. Schneider PA J Vasc Surg; 2017 Sep; 66(3):916-923. PubMed ID: 28842077 [TBL] [Abstract][Full Text] [Related]
16. Retrograde stent-graft angioplasty of superficial femoral artery occlusion in a claudicant. Lesperance RN; Singh NN; Curry TK; Andersen CA Vasc Endovascular Surg; 2009; 43(1):83-6. PubMed ID: 18829584 [TBL] [Abstract][Full Text] [Related]
17. Role of total endoluminal superficial femoral artery bypass. Gable D J Cardiovasc Surg (Torino); 2011 Oct; 52(5):683-700. PubMed ID: 21799474 [TBL] [Abstract][Full Text] [Related]
18. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease. Golchehr B; Lensvelt MM; Fritschy WM; Holewijn S; van Walraven LA; van Oostayen JA; Zeebregts CJ; Reijnen MM J Endovasc Ther; 2013 Dec; 20(6):836-43. PubMed ID: 24325702 [TBL] [Abstract][Full Text] [Related]
19. [Hemobahn-endoprosthesis: long-term experience (< or = 4 years follow-up) with percutaneous application in stenoses and occlusions of the superficial femoral artery]. Fischer M; Langhoff R; Schulte KL Zentralbl Chir; 2003 Sep; 128(9):740-5. PubMed ID: 14533042 [TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. Kedora J; Hohmann S; Garrett W; Munschaur C; Theune B; Gable D J Vasc Surg; 2007 Jan; 45(1):10-6; discussion 16. PubMed ID: 17126520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]